Cover Image
市場調查報告書

Allergy Therapeutics plc:產品平台分析

Allergy Therapeutics plc - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 224745
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Allergy Therapeutics plc:產品平台分析 Allergy Therapeutics plc - Product Pipeline Review - 2014
出版日期: 2014年01月31日 內容資訊: 英文 31 Pages
簡介

Allergy Therapeutics plc是開發過敏治療藥的特殊化型製藥企業。

本報告提供Allergy Therapeutics plc的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Allergy Therapeutics plc的基本資料

Allergy Therapeutics plc概要

  • 主要資訊
  • 企業資料

Allergy Therapeutics plc:R&D概要

  • 主要的治療範圍

Allergy Therapeutics plc:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Allergy Therapeutics plc:開發中產品概況

  • 後期開發中產品
    • 登記前的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Allergy Therapeutics plc:藥物簡介

  • Pollinex Quattro Grass
  • Pollinex Ragweed
  • Pollinex Quattro Tree
  • MPL-Based Allergy Vaccine
  • Pollinex Quattro Japanese Cedar

Allergy Therapeutics plc:開發平台分析

Allergy Therapeutics plc - Pipeline Products by Therapeutic Class

  • 各給藥途徑
  • 各分子類型

Allergy Therapeutics plc:最近的開發平台趨勢

Allergy Therapeutics plc:暫停中的計劃

Allergy Therapeutics plc:企業發表

Allergy Therapeutics plc:總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04652CDB

Global Market Direct's pharmaceuticals report, "Allergy Therapeutics plc - Product Pipeline Review - 2014" provides data on the Allergy Therapeutics plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Allergy Therapeutics plc's corporate website, SEC filings, investor presentations and featured press releases, both from Allergy Therapeutics plc and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

  • Allergy Therapeutics plc - Brief Allergy Therapeutics plc overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Allergy Therapeutics plc human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Allergy Therapeutics plc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Allergy Therapeutics plc's pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Allergy Therapeutics plc's strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Allergy Therapeutics plc in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Allergy Therapeutics plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Allergy Therapeutics plc.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Allergy Therapeutics plc and identify potential opportunities in those areas.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Allergy Therapeutics plc Snapshot
    • Allergy Therapeutics plc Overview
    • Key Information
    • Key Facts
  • Allergy Therapeutics plc - Research and Development Overview
    • Key Therapeutic Areas
  • Allergy Therapeutics plc - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Allergy Therapeutics plc - Pipeline Products Glance
    • Allergy Therapeutics plc - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Allergy Therapeutics plc - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Allergy Therapeutics plc - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Allergy Therapeutics plc - Drug Profiles
    • Pollinex Quattro Grass
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pollinex Ragweed
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pollinex Quattro Tree
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MPL-Based Allergy Vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pollinex Quattro Japanese Cedar
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Allergy Therapeutics plc - Pipeline Analysis
    • Allergy Therapeutics plc - Pipeline Products by Therapeutic Class
    • Allergy Therapeutics plc - Pipeline Products by Route of Administration
    • Allergy Therapeutics plc - Pipeline Products by Molecule Type
  • Allergy Therapeutics plc - Recent Pipeline Updates
  • Allergy Therapeutics plc - Dormant Projects
  • Allergy Therapeutics plc - Company Statement
  • Allergy Therapeutics plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Allergy Therapeutics plc, Key Information
  • Allergy Therapeutics plc, Key Facts
  • Allergy Therapeutics plc - Pipeline by Indication, 2014
  • Allergy Therapeutics plc - Pipeline by Stage of Development, 2014
  • Allergy Therapeutics plc - Monotherapy Products in Pipeline, 2014
  • Allergy Therapeutics plc - Pre-Registration, 2014
  • Allergy Therapeutics plc - Phase III, 2014
  • Allergy Therapeutics plc - Phase II, 2014
  • Allergy Therapeutics plc - Phase I, 2014
  • Allergy Therapeutics plc - Preclinical, 2014
  • Allergy Therapeutics plc - Pipeline by Therapeutic Class, 2014
  • Allergy Therapeutics plc - Pipeline by Route of Administration, 2014
  • Allergy Therapeutics plc - Pipeline by Molecule Type, 2014
  • Allergy Therapeutics plc - Recent Pipeline Updates, 2014
  • Allergy Therapeutics plc - Dormant Developmental Projects,2014
  • Allergy Therapeutics plc, Subsidiaries

List of Figures

  • Allergy Therapeutics plc - Pipeline by Top 10 Indication, 2014
  • Allergy Therapeutics plc - Pipeline by Stage of Development, 2014
  • Allergy Therapeutics plc - Monotherapy Products in Pipeline, 2014
  • Allergy Therapeutics plc - Pipeline by Top 10 Therapeutic Class, 2014
  • Allergy Therapeutics plc - Pipeline by Top 10 Route of Administration, 2014
  • Allergy Therapeutics plc - Pipeline by Top 10 Molecule Type, 2014
Back to Top